Larvol Delta - CBL0137-for-the-Treatment-of-Relapsed-or-Refractory-Solid-Tumors-Including-CNS-Tumors-and-Lymphoma

CBL137 IV - Incuron

http://clinicaltrials.gov/ct2/show/NCT04870944

Feb 8, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next